NASDAQ
Harpoon Therapeutics, Inc. (HARP) has a free cash flow growth of -9.52% as of Friday, May 29, 2026. This represents a 232.53% decrease compared to its 12-month average of 7.18%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.